Page 7 - ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Vials of the AstraZeneca and Pfizer-BioNTech Comirnaty coronavirus disease (COVID-19) vaccines are pictured in a General practitioners practice in Berlin, Germany, April 10, 2021. [Photo/Agencies] Combining different jabs would allow inoculation campaigns more flexibility Alternating doses of COVID-19 vaccines from Pfizer and AstraZeneca provides a robust immune response against the novel coronavirus, according to a United Kingdom study which could have significant implications for global vaccine rollout. An Oxford University-led trial of 830 volunteers showed that a mixed schedule of the vaccines induced high concentrations of antibodies against the COVID-19 spike protein when doses were administered four weeks apart, researchers said in a study published on The Lancet s preprint server.

United kingdomJonathan van tamBiontech comirnatyMatthew snapeAndrew ustianowskiUnited kingdom national institute for health researchVaccination programOxford universityHealth instituteOxford university ledUnited kingdom national instituteHealth researchஒன்றுபட்டது கிஂக்டம்ஜொனாதன் வேன் டாம்மேத்யூ ஸ்னேப்ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி